Correlating an 11-point verbal numeric rating scale to a 4-point verbal rating scale in the measurement of pruritis.

Autor: Jenkins HH, Spencer ED, Weissgerber AJ, Osborne LA, Pellegrini JE

Publikováno v: Journal of PeriAnesthesia Nursing; Jun2009, Vol. 24 Issue 3, p152-155, 4p

Strategies for implementing an electronic patient-reported outcomes-based symptom management program across six cancer centers.

Autor: Hassett M; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. michael_hassett@dfci.harvard.edu., Dias S; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA., Cronin C; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA., Schrag D; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., McCleary N; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA., Simpson J; Baptist Medical Center, 6019 Walnut Grove Rd, Memphis, TN, 38120, USA., Poirier-Shelton T; Baptist Medical Center, 6019 Walnut Grove Rd, Memphis, TN, 38120, USA., Bian J; Maine Medical Center, 22 Bramhall St, Portland, ME, 04102, USA., Reich J; Maine Medical Center, 22 Bramhall St, Portland, ME, 04102, USA., Dizon D; Lifespan Cancer Institute and Brown University, 593 Eddy St, Providence, RI, 02903, USA., Begnoche M; Lifespan Cancer Institute and Brown University, 593 Eddy St, Providence, RI, 02903, USA., Jenkins HH; West Virginia University Cancer Center, 1 Medical Center Dr, Morgantown, WV, 26506, USA., Tasker L; West Virginia University Cancer Center, 1 Medical Center Dr, Morgantown, WV, 26506, USA., Wong S; School of Medicine, Emory University, Atlanta, GA, 30322, USA., Pearson L; Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH, 03766, USA., Paudel R; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA., Osarogiagbon RU; Baptist Medical Center, 6019 Walnut Grove Rd, Memphis, TN, 38120, USA.

Publikováno v: BMC health services research [BMC Health Serv Res] 2024 Nov 12; Vol. 24 (1), pp. 1386. Date of Electronic Publication: 2024 Nov 12.

Assessing Patient Readiness for an Electronic Patient-Reported Outcome-Based Symptom Management Intervention in a Multisite Study.

Autor: Paudel R; Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Dana-Farber Cancer Institute, Boston, MA., Cronin C; Dana-Farber Cancer Institute, Boston, MA., Wong SL; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Dizon DS; Lifespan Cancer Institute and Brown University, Providence, RI., Jenkins HH; West Virginia University Cancer Center, Morgantown, WV., Bian J; Maine Medical Center, Portland, ME., Osarogiagbon RU; Baptist Memorial Healthcare Corporation, Memphis, TN., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Jan; Vol. 20 (1), pp. 77-84. Date of Electronic Publication: 2023 Nov 27.

Performance evaluation of a non-invasive one-step multiplex RT-qPCR assay for detection of SARS-CoV-2 direct from saliva.

Autor: Jenkins HH; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK. harry.jenkins1@nottingham.ac.uk., Lopez AAT; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Tarantini FS; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Tomlin H; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Scales D; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Lee IN; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Wu S; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Hyde R; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Lis-Slimak K; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Byaruhanga T; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Thompson JL; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Pijuan-Galito S; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Doolan L; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Kaneko K; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Gwynne P; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Reffin C; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Park E; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Dey J; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Hill J; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Arendt-Tranholm A; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Stroud A; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Petrie M; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Denning C; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK. chris.denning@nottingham.ac.uk., Benest AV; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK. andrew.benest@nottingham.ac.uk., Seedhouse C; School of Medicine, Biodiscovery Institute, University of Nottingham Asymptomatic Testing Service (UoNATS), University of Nottingham, University Park, Nottingham, NG7 2RD, UK. claire.seedhouse@nottingham.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2022 Jul 07; Vol. 12 (1), pp. 11553. Date of Electronic Publication: 2022 Jul 07.

Intraoperative Radiation Therapy Versus Whole Breast Radiation for Early-Stage Breast Cancer Treatment in Rural Appalachia.

Autor: Abdelsattar JM; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., McClain K; School of Medicine, West Virginia University, Morgantown, WV, USA., Afridi FG; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Wen S; Department of Biostatistics, West Virginia University, Morgantown, WV, USA., Cai Y; Department of Biostatistics, West Virginia University, Morgantown, WV, USA., Musgrove KA; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Bailey K; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Shaikh PM; Department of Radiation Oncology, West Virginia University, Morgantown, WV, USA., Jacobson GM; Department of Radiation Oncology, West Virginia University, Morgantown, WV, USA., Marsh W; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Lupinacci K; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Cowher MS; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA., Jenkins HH; 24041 Department of Surgery, West Virginia University, Morgantown, WV, USA.

Publikováno v: The American surgeon [Am Surg] 2020 Dec; Vol. 86 (12), pp. 1666-1671. Date of Electronic Publication: 2020 Aug 10.